Biosimilars 101: Facts, Risks & Opportunities

December 20, 2016

The emergence of biosimilars over the last few years has introduced a new competitive specialty pharmaceuticals market to combat the rising price tags on expensive biologics.

Previous Article
Premier Inc. Letter to Trump Administration
Premier Inc. Letter to Trump Administration

Premier recently recommended steps the incoming Trump Administration could take to solve some of healthcare...

Next File
The Post-Acute Care Conundrum
The Post-Acute Care Conundrum

Premier Inc. releases guide with decision-making resources to establish effective post-acute care partnersh...